long-term effects of glp-1 receptor agonists Frontiers Frontiers | GLP−1 receptor agonists

Many of these emerging players are based in China, indicating a potential shift in market dynamics unless major licensing or acquisition deals occur

It is healthier than sugar in moderate amounts

Importantly, as shown in a subset of patients, no significant cross-reaction was observed between anti-exenatide antibodies and human GLP-1 or glucagon

Suppress the release of glucagon (a hormone that raises blood sugar)

This suggests inhibition of vagal cholinergic input into the stomach with a concomitant increase in gastric volume, though the exact mechanism is not clear

pros and cons of GLP1 medications vs lifestyle programs for losing weight